Astrana Health Financials

ASTH Stock   33.47  0.23  0.68%   
Astrana Health is performing exceptionally good at this time. It has a great probability to report excellent financial results in January. As of now, Astrana Health's Total Stockholder Equity is increasing as compared to previous years. The Astrana Health's current Net Debt is estimated to increase to about 28.6 M, while Common Stock Total Equity is projected to decrease to under 30 K. Key indicators impacting Astrana Health's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.340.4533
Way Down
Slightly volatile
Current Ratio2.022.1105
Sufficiently Down
Slightly volatile
Investors should never underestimate Astrana Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Astrana Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Astrana Health.

Net Income

63.75 Million

  
Understanding current and past Astrana Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Astrana Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Astrana Health's assets may result in an increase in income on the income statement.

Astrana Health Stock Summary

Astrana Health competes with BioNTech, Valens, Arrow Electronics, Inhibrx, and Eltek. Astrana Health is entity of United States. It is traded as Stock on NASDAQ exchange.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS03763A2078
CUSIP03763A207 03763A108
Older SymbolAMEH
LocationCalifornia; U.S.A
Business Address1668 S Garfield
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.astranahealth.com
Phone626 282 0288

Astrana Health Key Financial Ratios

Astrana Health Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets728.7M817.5M867.4M966.2M933.4M980.0M
Other Current Liab77.0M74.1M88.5M128.5M184.1M193.3M
Net Debt153.3M67.1M(32.1M)(58.7M)27.2M28.6M
Retained Earnings31.9M69.8M137.2M182.4M243.1M255.3M
Accounts Payable6.9M9.6M5.5M10.5M9.1M9.5M
Cash103.3M193.5M233.1M288.0M293.8M308.5M
Total Liab367.7M372.3M356.7M407.7M522.6M548.7M
Total Current Assets329.1M338.6M404.5M428.1M461.5M484.6M
Common Stock35.9K42K45K47K54.1K33.4K
Short Term Debt12.6M14.2M3.9M4.8M24.8M26.0M
Net Receivables99.0M60.6M99.3M119.7M147.8M155.1M
Other Current Assets10.3M16.8M18.6M14.8M17.5M18.3M
Net Tangible Assets18.8M119.0M118.7M214.0M246.1M258.4M
Other Assets2.4M55.3M6.5M6.1M22.1M12.9M
Long Term Debt232.2M230.2M182.9M203.4M258.9M271.9M
Good Will238.5M239.1M246.4M269.1M278.8M139.8M
Long Term Debt Total232.2M230.2M182.9M203.4M233.9M245.6M
Capital Surpluse159.6M261.0M310.9M360.1M414.1M434.8M
Intangible Assets103.0M87.0M82.8M76.9M71.6M56.4M

Astrana Health Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense4.7M2.5M5.4M7.9M16.1M16.9M
Operating Income34.4M6.1M98.2M104.3M84.6M88.8M
Ebit34.4M187.9M83.1M94.5M105.9M111.2M
Income Before Tax25.8M8.9M77.7M86.6M89.8M94.3M
Net Income14.1M(23.8M)68.9M45.2M60.7M63.8M
Ebitda52.7M206.3M100.7M112.1M123.7M129.9M
Income Tax Expense8.2M9.2M31.7M40.9M32.0M33.6M
Total Revenue560.6M370.2M773.9M1.1B1.4B1.5B
Cost Of Revenue486.1M348.5M596.1M944.7M1.2B1.2B
Gross Profit74.5M21.7M177.8M199.5M215.0M225.7M
Minority Interest3.6M84.5M24.6M1.5M2.9M2.7M
Tax Provision8.2M56.1M28.5M36.1M32.0M22.8M
Interest Income2.0M2.8M1.6M2.0M14.2M14.9M
Net Interest Income(2.7M)(6.7M)(3.8M)(5.9M)(1.9M)(2.0M)

Astrana Health Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash(3.6M)90.0M39.1M54.9M6.1M5.8M
Free Cash Flow12.6M45.0M51.1M59.2M39.7M41.7M
Other Non Cash Items5.3M(102.1M)22.9M15.2M6.4M9.7M
Capital Expenditures1.0M1.2M19.2M22.9M28.5M30.0M
Net Income17.7M122.3M49.3M50.5M57.8M60.7M
End Period Cash Flow104.0M194.0M233.1M288.0M294.2M308.9M
Change To Inventory(29.6M)(5.8M)1.0M31.4M12.2M12.8M
Depreciation18.8M18.4M17.5M17.5M17.7M8.9M
Investments(129.7M)108.0M32.4M34.3M(65.5M)(62.2M)
Change Receivables(5.8M)15.6M(26.8M)(28.8M)(25.9M)(24.6M)
Net Borrowings281.4M(105K)(58.0M)(828K)(952.2K)(904.6K)
Dividends Paid61.7M51.3M31.1M14.0M(62.1M)(59.0M)
Change To Netincome2.3M(106.7M)(2.0M)(3.7M)(3.3M)(3.5M)

Astrana Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Astrana Health's current stock value. Our valuation model uses many indicators to compare Astrana Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Astrana Health competition to find correlations between indicators driving Astrana Health's intrinsic value. More Info.
Astrana Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.44  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Astrana Health is roughly  2.29 . As of now, Astrana Health's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Astrana Health's earnings, one of the primary drivers of an investment's value.

Astrana Health Systematic Risk

Astrana Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Astrana Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Astrana Health correlated with the market. If Beta is less than 0 Astrana Health generally moves in the opposite direction as compared to the market. If Astrana Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Astrana Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Astrana Health is generally in the same direction as the market. If Beta > 1 Astrana Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Astrana Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Astrana Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Astrana Health growth as a starting point in their analysis.

Price Earnings To Growth Ratio

1.04

As of now, Astrana Health's Price Earnings To Growth Ratio is increasing as compared to previous years.

Astrana Health December 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Astrana Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Astrana Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Astrana Health based on widely used predictive technical indicators. In general, we focus on analyzing Astrana Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Astrana Health's daily price indicators and compare them against related drivers.

Complementary Tools for Astrana Stock analysis

When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.